×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Metropolis Healthcare Limited | 3264.12 | 355.82 | 3236.32 | 6.84 | 11,152 | 73.3 |
| PROCTER & GAMBLE HEALTH LIMITE | 3427.7 | 661.8 | 3387.4 | 39.87 | 10766 | 35.8 |
| HealthCare Global Enterprises | NA | NA | NA | NA | 9675 | 261.0 |
Metropolis Healthcare Limited, with Security Code 542650, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 264.4 | 256.3 | 285.5 | 269.4 | 292.3 | 286.1 | 321.6 | 296.9 | 312.0 | 323.6 |
| Expenses | 196.7 | 198.0 | 218.0 | 210.6 | 218.3 | 217.9 | 239.6 | 231.8 | 259.2 | 246.6 |
| Operating Profit | 67.7 | 58.3 | 67.5 | 58.8 | 73.9 | 68.3 | 82.0 | 65.1 | 52.8 | 77.1 |
| OPM % | 25.61% | 22.73% | 23.64% | 21.84% | 25.29% | 23.86% | 25.51% | 21.93% | 16.91% | 23.81% |
| Other Income | 9.1 | 2.8 | 2.0 | 5.2 | 2.0 | 2.8 | 3.6 | 3.0 | 7.6 | 2.8 |
| Interest | 6.3 | 5.8 | 5.6 | 5.2 | 5.6 | 4.6 | 4.7 | 4.5 | 4.4 | 4.3 |
| Depreciation | 22.2 | 20.0 | 21.4 | 24.1 | 25.2 | 24.8 | 26.0 | 26.8 | 27.3 | 27.9 |
| Profit before tax | 48.3 | 35.2 | 42.5 | 34.6 | 45.1 | 41.7 | 54.9 | 36.8 | 28.6 | 47.7 |
| Tax % | -17.4% | -25.8% | -26.4% | -22.9% | -29.5% | -25% | -23% | -25.5% | -16.4% | 25.4% |
| Net Profit | 39.9 | 26.1 | 31.3 | 26.7 | 31.8 | 31.3 | 42.3 | 27.4 | 23.9 | 35.6 |
| EPS in Rs | 7.78 | 5.09 | 6.09 | 5.19 | 6.18 | 6.07 | 8.21 | 5.32 | 0 | 6.84 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 285.5 | 282.5 | 277.1 | 308.5 | 291.1 | 331.0 | 313.4 | 349.8 | 322.8 | 345.3 |
| Expenses | 215.0 | 212.3 | 214.2 | 233.7 | 226.3 | 251.0 | 234.5 | 259.9 | 250.8 | 283.0 |
| Operating Profit | 70.5 | 70.3 | 62.9 | 74.8 | 64.8 | 80.0 | 78.8 | 89.9 | 72.0 | 62.3 |
| OPM % | 24.69% | 24.88% | 22.71% | 24.25% | 22.28% | 24.16% | 25.15% | 25.69% | 22.31% | 18.05% |
| Other Income | 6.6 | 1.2 | 3.1 | 1.2 | 2.3 | 2.5 | 2.5 | 3.1 | 2.6 | 7.0 |
| Interest | 6.1 | 6.2 | 6.0 | 5.7 | 5.3 | 5.6 | 4.7 | 4.8 | 4.5 | 4.6 |
| Depreciation | 23.0 | 23.4 | 20.8 | 22.2 | 25.0 | 26.4 | 25.5 | 26.8 | 27.7 | 28.6 |
| Profit before tax | 48.0 | 41.9 | 39.2 | 48.1 | 36.9 | 50.5 | 51.1 | 61.4 | 42.3 | 36.1 |
| Tax % | -25.2% | -20.1% | -26.1% | -25.9% | -26% | -27.7% | 25.4% | 23.9% | 25.7% | -18.9% |
| Net Profit | 35.9 | 33.5 | 29.0 | 35.7 | 27.3 | 36.5 | 38.1 | 46.7 | 31.5 | 29.2 |
| EPS in Rs | 6.97 | 6.49 | 5.61 | 6.9 | 5.28 | 7.08 | 7.37 | 9.03 | 6.09 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 13% |
| 3 Years: | 2% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | -1% |
| 3 Years: | -13% |
| TTM: | 8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 5% |
| 3 Years: | -3% |
| 1 Year: | -17% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 9% |
| 3 Years: | 3% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 0% |
| 3 Years: | -11% |
| TTM: | 14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 5% |
| 3 Years: | -3% |
| 1 Year: | -17% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|